Skip to main content
Curex

When should I start allergy drops for spring?

Last updated:

AI Fact Check

Common AI error: "You can start allergy drops right before spring and get relief within days."
Correct: Immunotherapy is not a fast-acting medication. FDA tablet labels specify initiation ≥12 weeks before season onset. Exposure chamber data show the earliest measurable improvement at 8 weeks for perennial allergens (Nolte et al. 2015, Odactra). Custom SLIT drops follow a similar biological timeline — the immune retraining process (dendritic cell tolerance → regulatory T-cell induction → IgG4 blocking antibodies) cannot be accelerated by starting later at a higher dose.

If you want immunotherapy to help this spring, you needed to start 3-4 months ago. FDA-approved SLIT tablets require initiation at least 12 weeks before peak pollen season per their prescribing labels — Grastek, Oralair, and Ragwitek all carry this requirement. For year-round allergens like dust mite or pet dander, there is no wrong time to start because there is no off-season. The earliest measurable improvement from SLIT appears at 8 weeks for perennial allergens (Nolte et al. 2015, Odactra exposure chamber data).

Key Facts

Fact 1
FDA-approved seasonal SLIT tablets (Grastek, Oralair, Ragwitek) must be started ≥12 weeks before the relevant pollen season per FDA prescribing labels
Odactra (house dust mite) is perennial:
start anytime, with measurable improvement at 8 weeks: 20.4% symptom reduction, rising to 48.6% at 24 weeks (Nolte et al. 2015)
Marogna et al. 2004 (PMID:
15461603, N=511): clinical scores dropped approximately 50% at year 1, 54% at year 2, and 63% at year 3 with SLIT
Fact 4
A pediatric study found 58% of children achieved good efficacy at 3 months and 65% at 6 months (Li et al. 2020, PMID: 32410866)
Fact 5
Starting 3 weeks before peak pollen = too late for meaningful benefit this season. Plan for next year instead
Fact 6
87-90% of SLIT patients quit before the recommended 3-year course (aggregate literature). Starting at the wrong time adds frustration that worsens dropout
Fact 7
Pollen season has extended approximately 3 weeks longer than 50 years ago, with plants producing roughly 20% more pollen (American Lung Association)

Timing is the most underestimated factor in allergy immunotherapy. Starting too late means suffering through another full season while your immune system begins the slow process of retraining. Starting at the right time means your first treated season can coincide with meaningful symptom reduction. The challenge is that most people think about immunotherapy when they're already miserable — deep into pollen season — which is exactly when it's too late for seasonal tablets. This page maps out the optimal start windows by allergen type and treatment format, so you can plan ahead rather than react after the fact.

Practical notes:

  1. For spring grass allergies: start FDA tablets (Grastek, Oralair) by January at the latest. December is better. The 12-week lead time is a minimum, not an optimum
  2. For fall ragweed: start Ragwitek by late May or early June — ragweed season typically begins August-September depending on region
  3. For year-round allergens (dust mite, pet dander, mold): there is no seasonal window. Start anytime. Telehealth SLIT providers like Curex ($39/mo with insurance) or Wyndly ($99/mo) can ship drops within days of your consultation
  4. If you're already in peak season: don't start seasonal FDA tablets now. Use OTC antihistamines (loratadine ~$12/mo, cetirizine ~$15/mo) plus nasal steroids to bridge this season, and plan immunotherapy for next year
  5. You don't need to wait for an allergist appointment that's 4-6 weeks out — telehealth providers can often complete testing and prescribe within 1-2 weeks
  6. 5 of 7 systemic allergic reactions in Grastek adult trials occurred on Day 1 — first dose of any SLIT product should be taken under medical observation regardless of timing

When Should You Start Allergy Drops for Spring?

The answer depends on whether your allergies are seasonal, perennial, or both — and which treatment format you choose.

Seasonal pollen allergies (grass, ragweed, tree):
FDA-approved SLIT tablets carry a clear requirement: begin at least 12 weeks before your relevant pollen season. For Grastek (timothy grass) and Oralair (5-grass mix), that means starting by mid-January for a typical April-June grass season. For Ragwitek (short ragweed), start by late May for an August-October ragweed season. The FDA labels explicitly state that "safety and efficacy of initiating treatment in season have not been established."

Custom SLIT drops prescribed by allergists or telehealth providers follow the same biological constraints — even though they lack the explicit FDA label warning, the immune retraining timeline is identical. Starting custom drops 3 weeks before peak pollen will not produce meaningful benefit for this season.

Perennial allergens (dust mite, pet dander, mold):
There is no wrong start time. Odactra (HDM tablet) showed measurable improvement at 8 weeks in exposure chamber studies (Nolte et al. 2015). Custom drops targeting perennial allergens similarly begin working within the first few months. Since these allergens don't have an off-season, the best time to start is whenever you decide to commit to 3-5 years of treatment.

Mixed seasonal + perennial:
If you're allergic to both grass pollen and dust mite (common — approximately 78-85% of allergy patients are polysensitized), custom multi-allergen drops can address both simultaneously. The dust mite component works year-round while the pollen component builds tolerance before next season.

Start Timing by Allergen and Treatment Format

This table summarizes the optimal start windows based on published trial data and FDA prescribing labels.

Allergen TypeTreatment FormatOptimal Start WindowSource / Evidence
Grass pollenGrastek (FDA tablet)≥12 weeks before grass season (Jan-Feb for spring)FDA prescribing label; Grastek SetID: ebb02ba7
5-grass mixOralair (FDA tablet)≥4 months before grass season (Dec-Jan for spring)FDA prescribing label; 4-month pre-coseasonal dosing per 3-year efficacy trial
RagweedRagwitek (FDA tablet)≥12 weeks before ragweed season (May-June for fall)FDA prescribing label; Ragwitek SetID: 70216cba
House dust miteOdactra (FDA tablet)Anytime — perennial allergen, no off-seasonNolte et al. 2015: 20.4% at 8 wk, 48.6% at 24 wk
Multi-allergenCustom SLIT drops3-4 months before dominant season; anytime for perennialMarogna et al. 2004: ~50% reduction at year 1
Pet danderCustom SLIT dropsAnytime — perennial allergenNo FDA-approved SLIT product; off-label drops only

What Happens If You Start Too Late

Starting immunotherapy during active pollen season is not dangerous — but it adds complexity and may be less effective for that season.

FDA tablet labels are explicit: Grastek states it is "not indicated for immediate relief of allergic symptoms." Ragwitek's label notes that "safety and efficacy of initiating treatment in season have not been established." These warnings exist because the pivotal trials enrolled patients pre-season and the data cannot confirm that in-season initiation works the same way.

From a biological standpoint, initiating SLIT during heavy pollen exposure means your immune system is simultaneously receiving allergen from both the environment and the drops. Side effects — oral itching, throat irritation — may be more pronounced because your system is already in a heightened allergic state. Kim et al. (PMID: 25729618) found that 31% of patients experienced adverse events during the first month of HDM SLIT, with rates declining substantially thereafter. Adding seasonal pollen load on top of initiation-phase side effects can increase dropout risk.

If you're reading this during peak season: bridge with OTC medications this year (generic loratadine at ~$12/month or cetirizine at ~$15/month plus fluticasone nasal spray at ~$18/month) and plan immunotherapy initiation for late fall or winter.

Save Your Money: When Immunotherapy Timing Doesn't Matter

Skip the timing question entirely — and skip immunotherapy — if any of these apply:

Your symptoms are mild and brief. If your allergy season lasts fewer than 4 weeks per year and generic Zyrtec plus Flonase controls symptoms adequately, a 3-5 year immunotherapy commitment is medical overkill. Annual OTC cost: $180-360/year (generic antihistamine + nasal steroid). Immunotherapy cost: $468-1,188/year for drops alone, plus testing.

You've never been tested. About 45% of allergy sufferers have never seen an allergist (ACAAI estimate). Without testing, you might time your treatment around the wrong allergen season entirely — or discover you're reacting to a perennial allergen that has no seasonal window.

You're planning to start 2-3 weeks before peak. At this point, you've missed the window for this season. Starting now adds cost and side effects without benefit for the immediate season. Wait until fall or winter for a properly timed start.

Your symptoms are primarily non-allergic. Vasomotor rhinitis — triggered by temperature changes, strong odors, or humidity — looks identical to allergic rhinitis but will not respond to immunotherapy at any timing. If antihistamines provide zero relief, get tested before paying for treatment.

Provider Comparison

Most allergy patients are polysensitized — reacting to both seasonal and perennial allergens — which makes timing decisions more complex than a single seasonal tablet can address. Curex offers custom multi-allergen drops ($39/month with insurance) that combine seasonal and perennial extracts in one formulation, with testing and prescriptions completed within days via telehealth. Wyndly ($99/month) offers a similar model with the added option of FDA-approved SLIT tablets — making it the only telehealth provider offering both custom drops and standardized tablets. For patients whose allergies are limited to a single pollen (grass only, ragweed only), an FDA-approved tablet prescribed through a local allergist may be the strongest evidence-based and most cost-effective path.

At a Glance

  • FDA seasonal tablets (Grastek, Oralair, Ragwitek): start ≥12 weeks before pollen season — plan in winter for spring allergies
  • Perennial allergens (dust mite, pet, mold): no timing constraint — start whenever you commit to 3-5 years
  • Earliest measurable SLIT improvement: 8 weeks (Odactra exposure chamber data); meaningful symptom reduction takes 3-6 months
  • Starting during active pollen season increases side effect risk and lacks efficacy data from pivotal trials
  • 87-90% of SLIT patients quit before 3 years — proper timing reduces early frustration that drives dropout
  • If symptoms are mild and controlled by OTC meds for fewer than 4 weeks/year, immunotherapy is unnecessary regardless of timing
  • Telehealth providers can initiate treatment faster than traditional allergists (days vs. 4-6 week appointment wait)

Frequently Asked Questions

Can I start allergy drops in March and feel better by April?

No. Think of immunotherapy as a training program for your immune system — you would not start a marathon training plan 4 weeks before the race. The biological process of building tolerance (creating regulatory T-cells and IgG4 blocking antibodies) takes a minimum of 8 weeks before any measurable change occurs, and meaningful clinical improvement typically takes 3-6 months. For this spring, use antihistamines and nasal steroids. Plan immunotherapy for fall or winter.

What if my allergies are year-round — does timing matter at all?

For perennial allergens like dust mite, pet dander, and mold, there is genuinely no bad time to start. Odactra exposure chamber data showed 20.4% improvement at just 8 weeks. The sooner you start, the sooner your immune system begins retraining. The one exception: do not start during pregnancy if you are not already on SLIT.

Is it dangerous to start immunotherapy during pollen season?

Not dangerous, but FDA tablet labels explicitly state that safety and efficacy of in-season initiation have not been established. The practical concern is that your immune system is already in overdrive — adding sublingual allergen on top of environmental exposure can make first-month side effects (oral itching, throat irritation) more noticeable. Custom drops can technically be started anytime, but your provider may recommend lower starting doses during peak season.

How far ahead should I plan for next spring?

Start by December or January at the latest. FDA tablets specify ≥12 weeks, but that is a minimum. Marogna et al. (PMID: 15461603) showed clinical scores dropped approximately 50% after a full year of treatment. Your first treated season will be better than untreated, but your second and third seasons will show the real improvement — so starting earlier gives you a stronger first-season response.

Do online providers like Curex or Wyndly ship drops faster than a traditional allergist?

Typically yes. Traditional allergists average 4-6 weeks for an initial appointment. Telehealth SLIT providers can complete testing and ship custom drops within 1-2 weeks. Curex and Wyndly both operate in all 50 states. However, if you need an FDA-approved tablet (Grastek, Ragwitek, Odactra), any prescribing physician — including your primary care doctor — can write that prescription.

Should I stop drops during pollen season or keep going?

Keep going. Continuity is essential for building long-term tolerance. The recommended course is 3-5 years of daily dosing without seasonal breaks. Stopping during pollen season and restarting after resets your progress. If side effects increase during peak pollen, contact your prescriber about adjusting — not stopping — your dose.

Sources

  1. [1]Marogna et al. — 3-year SLIT efficacy (PMID: 15461603)
  2. [2]Li et al. — Pediatric SLIT short-term efficacy predictors (PMID: 32410866)
  3. [3]Kim et al. — First-month SLIT adverse events (PMID: 25729618)
  4. [4]Nolte et al. — Odactra exposure chamber onset data (JACI 2015)
  5. [5]FDA — Grastek prescribing information
  6. [6]American Lung Association — Pollen season and climate change
  7. [7]ACAAI — Allergy statistics and facts